22 1. Hiom SC. Diagnosing cancer earlier: reviewing the evidence for improving cancer survival. Br J Cancer 2015;112 (suppl 1):S1-5. 2. Hawkes N. Cancer survival data emphasise importance of early diagnosis. BMJ 2019;364:1408. 3. Wingo PA, Cardinez CJ, Landis SH et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 2003;97(suppl 12):3133-75. 4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30. 5. Miller KD, Nogueira L, Mariotto AB et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019;69:363-85. 6. Dagenais GR, Leong DP, Rangarajan S et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet 2020;395:785-94. 7. Sung H, Ferlay J, Siegel RL et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:20949. 8. https://gco.iarc.fr/tomorrow/home (20 August 2021, date last accessed). 9. https://iknl.nl/nkr-cijfers (20 August 2021, date last accessed). 10. Kroenke K, Zhong X, Theobald D et al. Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med 2010;170:1686-94. 11. Reilly CM, Bruner DW, Mitchell SA et al. A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer 2013;21:1525-50. 12. Teunissen SC, Wesker W, Kruitwagen C et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007;34:94-104. 13. Deshields TL, Potter P, Olsen S, Liu J. The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer 2014;22:1089-96. 14. Kehl KA. Moving toward peace: an analysis of the concept of a good death. Am J Hosp Palliat Care 2006;23:277-86. 15. Teno JM, Clarridge BR, Casey V et al. Family perspectives on end-of-life care at the last place of care. JAMA 2004;291:8893. 16. Cheville AL, Alberts SR, Rummans TA et al. Improving adherence to cancer treatment by addressing quality of life in patients with advanced gastrointestinal cancers. J Pain Symptom Manage 2015;50:321-7. 17. Bruera E, Yennurajalingam S. Palliative care in advanced cancer patients: how and when? The Oncologist 2012;17:26773. 18. Goldberg SL, Paramanathan D, Khoury R et al. A patient-reported outcome instrument to assess symptom burden and predict survival in patients with advanced cancer: flipping the paradigm to improve timing of palliative and end-of-life discussions and reduce unwanted health care costs. The Oncologist 2019;24:76-85. 19. Temel JS, Greer JA, Muzikansky A et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733-42. 20. Bakitas MA, Tosteson TD, Li Z et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 2015;33:1438-45. References
RkJQdWJsaXNoZXIy MjY0ODMw